Export boost for Duopharma

Leonard Ariff: We are continuously looking to enhance our facilities and processes to ensure we comply with regulatory bodies like the US FDA.

MALAYSIA’S pharmaceutical industry relies heavily on the public sector, which buys around 70% of generic drugs in the market.

Duopharma Biotech Bhd reflects this trend, with half of its products supplied to the public sector, 42% to the private sector, and the remaining 8% exported.